I assume although the Triangle report is for BC, Race is now pursuing all Cancer types where Bisantrene acts as a cardio protective drug with anti cancer properties. If so, the market potential is definitely very large. How do you even calculate? 5B for BC + (5B x 100 other cancer types) = 505B. Is my valuation getting a bit Hunterish?
Ann: Updated Strategy and Investor Presentation, page-469
-
- There are more pages in this discussion • 40 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.59 |
Change
0.000(0.00%) |
Mkt cap ! $270.9M | |||
| Open | High | Low | Value | Volume |
| $1.59 | $1.62 | $1.57 | $180.6K | 113.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 145 | $1.57 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.60 | 23400 | 1 |
View Market Depth
| Last trade - 16.10pm 15/10/2024 (20 minute delay) ? |
| RAC (ASX) Chart |